Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Clinical research is ongoing, and long-term outcomes are still being studied
Retatrutide availability is primarily through research chemical suppliers, and the market is growing as more researchers begin exploring this triple-agonist peptide
Individual results with compounded formulations should approximate these outcomes if the active ingredient is equivalent, though individual variation is significant
Without gastric POCUS imaging with this patient, we would not have known about the significant residual gastric volume
As long as it is not being used to subvert state laws or infringe on intellectual property rights, compounding is literally life saving for some patients
Compare options at PlexusDx product pages for your dose tier
